昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
昭衍新药(603127) 利润表
单位:万元
报表日期2021-09-302021-06-302021-03-312020-12-312020-09-30
一、营业总收入85,680.4453,455.6520,099.25107,590.4963,151.33
营业收入85,680.4453,455.6520,099.25107,590.4963,151.33
二、营业总成本68,999.3947,750.8711,132.4980,430.5852,218.35
营业成本43,091.1126,324.889,732.8352,309.2131,714.74
营业税金及附加639.89466.45160.54653.51473.69
销售费用1,161.09725.36319.771,290.73978.57
管理费用19,553.6913,126.156,710.9620,863.5014,095.35
财务费用1,051.624,921.98-6,779.50247.7467.45
研发费用3,501.992,186.05987.885,065.904,888.55
资产减值损失----------
公允价值变动收益8,006.969,202.9890.255,894.58244.48
投资收益1,199.52546.35178.71152.37151.15
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润28,154.4717,386.6410,780.3536,111.8113,361.48
加:营业外收入3.833.470.671.641.43
减:营业外支出128.09126.97377.4256.2453.42
其中:非流动资产处置损失----------
四、利润总额28,030.2117,263.1410,403.6036,057.2113,309.49
减:所得税费用3,329.261,953.811,093.594,694.431,588.78
五、净利润24,700.9515,309.349,310.0031,362.7811,720.71
归属于母公司所有者的净利润24,800.6215,373.499,335.7331,501.3911,828.41
少数股东损益-99.66-64.16-25.72-138.61-107.69
六、每股收益
基本每股收益(元/股)0.95000.60000.39001.40000.5200
稀释每股收益(元/股)0.94000.59000.38001.39000.5200
七、其他综合收益-144.18-236.65-3,071.112,851.123,420.18
八、综合收益总额24,556.7715,072.686,238.8934,213.9015,140.89
归属于母公司所有者的综合收益总额24,656.4315,136.846,264.6234,352.5115,248.58
归属于少数股东的综合收益总额-99.66-64.16-25.72-138.61-107.69
下载全部历史数据到excel中 返回页顶